The Asia Pacific digital genome market is expected to reach US$ 4,118.86 million by 2027 from US$ 2,077.27 million in 2019; it is estimated to grow at a CAGR of 9.1% from 2020 to 2027.
The key factors driving the growth of digital genomeare increasing prevalence of chronic diseases and growing funding for genomics in the region. However, dearth of skilled professional is the major factor hindering the market growth in Asia Pacific.
The digital genome is advanced progress in understanding animal and plant genetic material is being driven through advancements in DNA sequencing technology. It helps in gathering information related to chronic diseases and utilized to get an understanding of genetic disorders. A digital genome facilitates instant access to trait sequences to resolve unending custom queries.
According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality. The WHO also suggests that 30–50% of deaths caused due to cancer can be prevented by adequate treatment in the early stages. In this scenario, personalized medicine offers the most promising approaches to tackle diseases, which have far eluded effective treatments or cures. Biopharmaceutical researchers also predict a 69% increase in the number of personalized medicines in development over the coming five years.
Also, many of the most intractable health challenges, from heart disease to cancer, have a genetic component. Indeed, cancer is best described as a disease of the genome. With digitization, doctors will be able to make decisions about a patient’s cancer treatment informed by a tumor’s genetic make-up. This new knowledge is also making precision medicine a reality by enabling the development of highly targeted therapies that offer the potential for improved treatment outcomes, especially for patients battling cancer. Increasing the adoption of personalized medicines for disease treatments using the patient’s genetic information is expected to aid in offering targeted treatment. This, in turn, is expected to create lucrative growth opportunities for the Asia Pacific digital genome market in the near future.
Asia Pacific countries are expecting to witness huge challenge due to growing COVID-19. Considering the economic operations and geographic condition, the outbreak of disease has affected the healthcare infrastructure in Asia Pacific low-income countries. The Countries in Asia have started studying the genome of corona virus. Similarly, Indian scientists have started genome sequencing of the strains of the coronavirus This is the part of large sequencing project led by the New Delhi-based National Centre for Disease Control. Thus, such genome sequencing activities is expected to favour the growth of digital genome in Asia Pacific region.
Rest of Asia Pacific Digital Genome Market,Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFICDIGITAL GENOME MARKET SEGMENTATION
By Product
- Sequencing and Analyzer Instruments
- DNA/RNA Analysis
- Sequencing and Analysis Software
- Sequencing Chips
- Sample Prep Instruments
By Application
- Diagnostics
- Drug Discovery
- Academic Research
- Personalized Medicine
- Agricultural
- Other
By End-User
- Diagnostics and Forensic Labs
- Academic Research Institutes
- Hospitals
- Other
By Country
- China
- Japan
- India
- South Korea
- Australia
Company Profiles
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc
- F. HOFFMANN-LA ROCHE LTD
- QIAGEN
- bioMerieux SA
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Digital Genome Market – By Product
1.3.2 Asia Pacific Digital Genome Market – By Application
1.3.3 Asia Pacific Digital Genome Market– By End User
1.3.4 Asia Pacific Digital Genome Market – By Country
2. Asia Pacific Digital Genome Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Digital Genome Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Digital Genome Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Digital Genome Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Funding for Genomics
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Key Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Increasing Technological Advancement in Digital Genome Field
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicines
5.5 Impact Analysis
6. Digital Genome Market – Asia Pacific Analysis
6.1 Asia Pacific Digital Genome Market Revenue Forecasts and Analysis
7. Asia Pacific Digital Genome Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 Asia Pacific Digital Genome Market, By Product 2019 & 2027 (%)
7.2.1 Asia Pacific Digital Genome Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 DNA/RNA Analysis
7.3.1 Overview
7.3.2 Asia Pacific DNA/RNA Analysis Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Sequencing and Analyzer Instruments
7.4.1 Overview
7.4.1.1 Asia Pacific Sequencing and Analyzer Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Sequencing and Analysis Software
7.5.1 Overview
7.5.2 Asia Pacific Sequencing and Analysis Software Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Sequencing Chips
7.6.1 Overview
7.6.2 Asia Pacific Sequencing Chips Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Sample Prep Instruments
7.7.1 Overview
7.7.2 Asia Pacific Sample Prep Instruments Market Revenue and Forecast to 2027 (US$ Mn)
8. Asia Pacific Digital Genome Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 Asia Pacific Digital Genome Market, By Application 2019 & 2027 (%)
8.2.1 Asia Pacific Digital Genome Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Diagnostics
8.3.1 Overview
8.3.2 Asia Pacific Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Asia Pacific Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Academic Research
8.5.1 Overview
8.5.2 Asia Pacific Academic Research Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Personalized Medicine
8.6.1 Overview
8.6.2 Asia Pacific Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Agricultural
8.7.1 Overview
8.7.2 Asia Pacific Agricultural Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Asia Pacific Digital Genome Market Analysis – By End-User
9.1 Overview
9.2 Asia Pacific Digital Genome Market, By End-User 2019-2027 (%)
9.2.1 Asia Pacific Digital Genome Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Diagnostics and Forensic Labs
9.3.1 Overview
9.3.2 Asia Pacific Diagnostics and Forensic Labs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Academic Research Institutes
9.4.1 Overview
9.4.2 Asia Pacific Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Hospitals
9.5.1 Overview
9.5.2 Asia Pacific Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Digital Genome Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Asia Pacific Digital Genome Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Asia Pacific: Digital Genome Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Asia Pacific: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.4 Asia Pacific: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.5 Asia Pacific: Digital Genome Market, by End User, 2018–2027 (USD Million)
10.1.6 Asia Pacific: Digital Genome Market, by Country, 2019 & 2027 (%)
10.1.7 China: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 China: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 China: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.7.3 China: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.7.4 China: Digital Genome Market, by End User, 2018–2027 (USD Million)
10.1.8 Japan: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Japan: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Japan: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.8.3 Japan: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.8.4 Japan: Digital Genome Market, by End User, 2018–2027 (USD Million)
10.1.9 India: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 India: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 India: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.9.3 India: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.9.4 India: Digital Genome Market, by End User, 2018–2027 (USD Million)
10.1.10 South Korea: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 South Korea: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 South Korea: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.10.3 South Korea: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.10.4 South Korea: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.11 Australia: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Australia: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Australia: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.11.3 Australia: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.11.4 Australia: Digital Genome Market, by End User , 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific Digital Genome Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 QIAGEN
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 bioMerieux SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 THERMO FISHER SCIENTIFIC INC
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Illumina, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Digital Genome Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. Asia Pacific Digital Genome Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. Asia Pacific Digital Genome Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 4. Asia Pacific Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 6. Asia Pacific Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 7. China Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. China Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 9. China Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 10. Japan Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Japan Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 12. Japan Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 13. India Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. India Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 15. India Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 16. South Korea Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 17. South Korea Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 18. South Korea Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 19. Australia Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 20. Australia Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 21. Australia Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 22. Glossary of Terms, Digital Genome Market
LIST OF FIGURES
Figure 1. Digital Genome Market Segmentation
Figure 2. Asia Pacific Digital Genome Market Overview
Figure 3. The Sequencing and Analyzer Instruments Segment Held Largest Share of Digital Genome Market
Figure 4. China is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Digital Genome Market - Leading Country Markets (US$ Mn)
Figure 6. Digital Genome Market - Asia Pacific PEST Analysis
Figure 7. Digital genome Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Digital Genome Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Asia Pacific Digital Genome Market, By Product 2019 & 2027 (%)
Figure 10. Asia Pacific DNA/RNA Analysis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Sequencing and Analyzer Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Sequencing and Analysis Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Sequencing Chips Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Sample Prep Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Digital Genome Market, By Application 2019 & 2027 (%)
Figure 16. Asia Pacific Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Academic Research Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Asia Pacific Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific Agricultural Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia Pacific Digital Genome Market, by End-User 2019 & 2027 (%)
Figure 23. Asia Pacific Diagnostics and Forensic Labs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Asia Pacific Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Asia Pacific Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Asia Pacific: Digital Genome Market, by Key Country – Revenue (2019) (USD Million)
Figure 28. Asia Pacific Digital Genome Market Revenue and Forecast to 2027 (USD Million)
Figure 29. China: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Japan: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. India: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. South Korea: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Australia: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
The List of Companies - Asia Pacific Digital Genome Market
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc
- F. HOFFMANN-LA ROCHE LTD
- QIAGEN
- bioMerieux SA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Digital Genome Market
Jul 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jul 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jul 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jul 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jul 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jul 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Jul 2020